RENEE LAMM: Open Payments
NPI 1245214592 · MYRTLE BEACH, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$260,731 in 390 payments from 18 companies in 2025. Trend: 2023 $315,064 · 2024 $212,490 · 2025 $260,731
Speaker / faculty: $124,470Honoraria: $99,743Travel & lodging: $21,914Consulting: $8,025Food & beverage: $6,579
| Company | Payments | Amount |
|---|---|---|
| Axsome Therapeutics, Inc. | 116 | $112,850 |
| Otsuka America Pharmaceutical, Inc. | 95 | $70,843 |
| Teva Pharmaceuticals USA, Inc. | 36 | $36,428 |
| Alkermes, Inc. | 21 | $16,435 |
| Vanda Pharmaceuticals Inc. | 24 | $9,960 |
| ABBVIE INC. | 51 | $7,265 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 18 | $6,276 |
| E.R. Squibb & Sons, L.L.C. | 5 | $179 |
| Tris Pharma Inc | 6 | $105 |
| Lundbeck LLC | 4 | $84 |
Products named: Auvelity, REXULTI, AUSTEDO XR, FANAPT, LYBALVI, VRAYLAR, VIVITROL, CAPLYTA.
Industry payments across SC — which companies pay providers there.
